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7he auloimmune phenomena associated with many human diseases are still only partially undersrood. Unravrllir~g the molecular pathogenesis of inherited diseases wirh a srrong auroimmune component in their clinical upression could help to dissect the molecular background of abnormal immune response. One such genetic disorder is aurosomal resessive autoimmune polyglandular disease type I (PGD I), also known a s auroir~~mune polyendocrinoparhy -candidiasisectodermal dystrophy (APECED, MIM 240300). 7his disease is especially enriched in the generically isolaredpopularion of Finland. Here we have taken advanrage of neujly developed anrplifiable multi~!!r!ic microsatellite markers coupled with the microtirer well forn~at of rhe polyn~erase chain reacrion and linkage analyses to establish the most probable ct~romosomal location for (he APECED locus. 7he rapid "semiaurumated" prorocol was here aplied to analyze I00 chron~osomally assigned polymorphic loci. n e merhod proved to be an eflctive and economical roo1 for gene mapping compared with standard blorting and hybridization and resulted in the preliminary assignment of the APECED lucw. assocmted with lower collagen synthesis. Since adrenal funct~on was similar In all groups of patients, the higher estrone blood levels i n obese wflh striae may be due lo aromatase actlvny ol fat tissue. 
RANDOMIZED TRIAL OF THE EFFECT OF TWO DIFFERENT PROGE-STAGENS ON PLASMA LIPIDS I N GIRLS TREATED FOR

n a d u l t women p r o g e s t e r o n e d e r i v a t i v e s h a v e b e e n a d v o c a t e d t o b e p r e f e r a b l e t o n o r t e s t o s t e r o n e compounds d u e t o t h e i r l e s s n e g a t i
v e e f f e c t s o n s e r u m HDL l e v e l s . S i n c e c o m p a r a b l e d a t a o n p a e d i a t r i c p a t i e n t s a r e l a c k i n g , we s t u d i e d 24 t a l l g i r l s r a n d o m l y a s s i g n e d t o e i t h e r 5 mg o f m e d r o x y p r o g e s t e r o n e a c e t a t e ( g r o u p A) o r 5 mg n o r e t h i s t e r o n e a c e t a t e ( g r o u p 8 ) d a i l y ( d a y s 13-23) i n a d d i t i o n t o 7 . 5 mg o f c o n j u g a t e d e s t r o g e n s ( P r e s o m e n ) d a i l y . G r o u p A a n d B d i d n o t d i f f e r i n a g e a n d b o n e a g e , h e i g h t , w e i g h t , b o d y m a s s i n d e x (BMI), p r e d i c t e d a d u l t h e i g h t (PAH), p l a s m a c h o l e s t e r o l ( 4 . 3 f 0 . 9 v s 4 . 4 + 0 . 6 mM; mean + S D ) , t r i g l y c e r i d e s ( 0 . 9 3 f 0 . 3 7 v s 0 . 7 5 f 0 . 2 3 mM), HDL-( 1 . 2 f 0 . 2 v s 1 . 3 + 0 . 3 mM), LDL-choles t e r o l ( 2 . 6 i 0 . 8 v s 2 . 6 i 0 . 6 mM) a n d HDL/LDL-ratio ( 0 . 6 6 i 0 . 4 1 v s 0 . 5 2 i 0 . 1 4 ) . A l l p a r a m e t e r s w e r e f o llowed a t 0 , 3 , 6 , 9 , 1 2 , 1 8 m o n t h s d u r i n g t r e a t m e n t a n d 6 mo t h e r e a f t e r . Between a n d w i t h i n g r o u p s A a n d B t h e r e was n o d i f f e r e n c e / c h a n g e o f a n y p l a s m a l i p i d p a r a m e t e r d u r i n g a n d a f t e r t r e a t m e n t . PAH, n e a r f i n a l h e i g h t a n d RMT a f t e r t r e a t m e n t w e r e c o m~a r a b l e i n b o t h nrnnnc wn The rrllahlllty oiprovncsl#ur s t m t # l~ ~I t l l ~r . r r l # o n #n I h dsagnurhr oiCH drric~rnry t l 1s rllll unclear. Unill now v a~,~c r l i f G~l ra,plin\c cu vanuu, r~lrilvll arc >~a n l ) T,) .ddrrir P a n < , in a wry Iargc poliulalion or chlldrrn 811,wl io h m c r dlrrcrint,a~r blrurcn normal and ~~~~~~~d pllultury funitbun, bought a nomat GI4 r<,p,jnrc lo S25 hcsr tellr dorr not ,I, cnxt ul, cxl\wnic h!porctrctnry natc due a! h!pcilhsIrs!. d~riunrtlon
To idcritify slructur;il c o n i p o n c n t s csscritial for lig:ind b i n d i n g i n A T ! r c c c p t o r , \vc r n u l a l c d :~n d I r ;~n s i c n t l y c n p r c s s c d t h c m o d i f i e d r:lt AT1 rcccptors it1 COS7 cclls and cxarnincd chnngcs i n l i g a n d b i n d i n g : r c t i \ i l y . Wc h a d i~l r c a d y r c p o r t c d ! h a 1 t h c r c p l a c c r n c n r o f o n y o n c o f 4 C y s w i t h G l y in t h
